文献速递脊柱外科

成人症状性腰椎侧凸手术治疗与非手术治疗在八年随访时的成本效果改善

Cost-effectiveness Improves for Operative Versus Non-operative Treatment of Adult Symptomatic Lumbar Scoliosis at Eight-year Follow-up.
PubMed 文献 · Spine (Phila Pa 1976) · 2024-10-14

该研究对NIH资助的成人症状性腰椎侧凸(ASLS)队列进行二次数据分析,比较手术(Op)与非手术(Non-Op)治疗在入组8年时的成本效果。按治疗分析显示Op组每获得一个QALY的增量成本效果比(ICER)为20,569美元,较5年时的44,033美元继续改善;意向性分析显示Op组QALY增益更大且成本更低(ICER=-13,911美元)。结论认为在8年随访时Op治疗比Non-Op治疗更具成本效果。

要点

  • 按治疗分析显示Op组ICER为每QALY 20,569美元,处于支付意愿阈值内。
  • 意向性分析显示Op组QALY增益更大且成本更低,ICER=-13,911美元。
  • ICER从5年时的44,033美元改善至8年时的20,569美元。

核心结论

  • 在8年随访时,成人症状性腰椎侧凸的手术治疗比非手术治疗更具成本效果。

研究设计与样本

  • 研究为对NIH资助的成人症状性腰椎侧凸(ASLS)研究进行的二次数据分析。
  • 前2年每3个月收集一次数据,之后每6个月收集一次直至研究结束。
  • 数据包括非手术方式使用、药物和就业状况;费用采用Medicare允许费率、RedBook及基于就业状况和收入的间接成本计算。
  • 采用Short Form-6 Dimensions确定质量调整生命年(QALYs)。
  • Op组101例、Non-Op组103例具有完整8年数据;Non-Op组中38例(37%)在入组后3至72个月期间接受了手术。

主要发现

  • 按治疗分析仅纳入从未手术者(N=65)或具有完整术后8年数据者(N=101),显示Op治疗更优,ICER为每QALY 20,569美元,处于支付意愿阈值内。
  • 意向性分析显示Op组QALY增益更大且成本更低(ICER=-13,911美元)。
  • 意向性分析受Non-Op组患者在随访期间不同时间交叉接受Op治疗的影响。

关键数值与推荐

  • 按治疗分析ICER为每QALY 20,569美元,处于支付意愿阈值内。
  • 意向性分析ICER为-13,911美元。
  • 5年时按治疗分析ICER为44,033美元,意向性分析ICER为27,480美元。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 意向性分析受Non-Op组患者在随访期间不同时间交叉接受Op治疗的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY DESIGN: Secondary data analysis of the NIH-sponsored study on adult symptomatic lumbar scoliosis (ASLS). OBJECTIVES: The purpose of this study is to perform a cost-effectiveness analysis comparing operative (Op) versus non-operative (Non-Op) care for ASLS 8 years after enrollment. BACKGROUND: A prior cost-effectiveness analysis of the current cohort comparing Op to Non-Op care at 5 years after enrollment showed an incremental cost-effectiveness ratio (ICER) of $44,033 in the as-treated analysis and an ICER of $27,480 in the intent-to-treat analysis. MATERIALS AND METHODS: Data were collected every 3 months for the first 2 years, and then every 6 months for the remainder of the study. Data included the use of Non-Op modalities, medications, and employment status. Costs for index and revision surgeries and Non-Op modalities were determined using Medicare Allowable rates. Medication costs were determined using the RedBook and indirect costs were calculated based on reported employment status and income. Quality-adjusted life years (QALYs) were determined using the Short Form-6 Dimensions. RESULTS: There were 101 cases in the Op and 103 in the Non-Op group with complete 8-year data. Thirty-eight patients (37%) in the Non-Op group had surgery from 3 to 72 months after enrollment. An as-treated analysis including only cases who never had surgery (N = 65) or cases with complete 8-year postoperative data (N = 101) showed that Op treatment was favored with an ICER of $20,569 per QALY gained, which is within willingness-to-pay thresholds. An intent-to-treat analysis demonstrated greater QALY gains and lower costs in the Op group (ICER = -$13,911). However, intent-to-treat analysis is influenced by Non-Op patients who crossed over to Op treatment at variable times during follow-up. CONCLUSION: Op treatment was more cost-effective than Non-Op treatment for ASLS at 8-year follow-up. The ICER continued to improve as compared with the 5-year values ($20,569 vs . $44,033).

来源:Spine (Phila Pa 1976),查看原文。版权归原作者所有。

引用

  1. Carreon LY, Glassman SD, Smith JS, et al. Cost-effectiveness Improves for Operative Versus Non-operative Treatment of Adult Symptomatic Lumbar Scoliosis at Eight-year Follow-up. Spine (Phila Pa 1976). 2024. PMID: 39397347. doi:10.1097/BRS.0000000000005186

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。